Ipca Laboratories Limited Ipca Laboratories Limited

Ipca Laboratories Limited

IPCALAB

Classement en actions #3415
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Prix de l'action
$20.02
Dernière synchronisation: 2026-10-19
Capitalisation boursière
$5.08B
Changement (1 jour)
-1.65%
Changement (1 an)
38.46%
Pays
IN
Échange Ipca Laboratories Limited (IPCALAB)

Catégorie

Healthcare
Historique des divisions d’actions pour Ipca Laboratories Limited (IPCALAB)
L’action Ipca Laboratories Limited (symbole : IPCALAB) a subi un total de 3 divisions.
La division la plus récente a eu lieu le Jan 10, 2022.
Une action IPCALAB achetée avant le Jan 28, 2005 équivaudrait aujourd’hui à 20 actions IPCALAB.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
2022-01-10 2:1 x2 x20
2010-03-22 5:1 x5 x10
2005-01-28 2:1 x2 x2
Divisions d’actions d’entreprises similaires ou concurrentes